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Abstract
Background Since the implementation of total mesorectal excision (TME) in rectal cancer surgery, oncological outcomes
improved dramatically. With the technique of complete mesocolic excision (CME) with central vascular ligation (CVL), the
same surgical principles were introduced to the field of colon cancer surgery. Until now, current literature fails to invariably
demonstrate its oncological superiority when compared to conventional surgery, and there are some concerns on increased
morbidity. The aim of this study is to compare short-term outcomes after left-sided laparoscopic CME versus conventional
surgery.
Methods In this retrospective analysis, data on all laparoscopic sigmoidal resections performed during a 3-year period (October
2015 to October 2018) at our institution were collected. A comparative analysis between the CME group—for sigmoid colon
cancer—and the non-CME group—for benign disease—was performed.
Results One hundred sixty-three patients met the inclusion criteria and were included for analysis. Data on 66 CME resections
were compared with 97 controls. Median age and operative risk were higher in the CME group. One leak was observed in the
CME group (1/66) and 3 in the non-CME group (3/97), representing no significant difference. Regarding hospital stay, postop-
erative complications, surgical site infections, and intra-abdominal collections, no differences were observed. There was a
slightly lower reoperation (1.5% versus 6.2%, p = 0.243) and readmission rate (4.5% versus 6.2%, p = 0.740) in the CME group
during the first 30 postoperative days. Operation times were significantly longer in the CME group (210 versus 184 min,
p < 0.001), and a trend towards longer pathological specimens in the CME group was noted (21 vs 19 cm, p = 0.059).
Conclusions CME does not increase short-term complications in laparoscopic left-sided colectomies. Significantly longer oper-
ation times were observed in the CME group.
Keywords Colonic neoplasm . Sigmoid neoplasm . Complete mesocolic excision . Central vascular ligation . Laparoscopic
surgery
Introduction
Background The introduction of the total mesorectal excision
(TME) technique for the surgical treatment of rectal cancer in
1979 dramatically improved oncological outcomes [1]. By
adhering to the principles of a sharp dissection along embry-
ological anatomical planes, thereby removing all draining
lymphatic tissue with an intact coverage, both local recurrence
rates and survival rates were ameliorated significantly [1, 2].
With the technique of complete mesocolic excision (CME)
and central vascular ligation (CVL), the same surgical princi-
ples were introduced to the field of colon cancer surgery.
Generally, the Erlangen group is considered as the first to
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describe this technique [3]. Some advocate that these princi-
ples have been part of a “good surgical practice” for decades,
and authors reported on similar surgical principles before
2009 [4, 5].
In their initial paper on 1329 patients, Hohenberger et al.
reported on excellent oncological outcomes with the adoption
of the CME technique. Local 5-year recurrence rates dropped
from 6.5 to 3.6%, and the 5-year survival rates increased from
82.1 to 89.1% [3]. Similarly, Bokey et al. reported in 2003 on
superior oncological results with a more radical surgical tech-
nique, demonstrating an improvement in 5-year overall sur-
vival from 48 to 63% [4]. More recently, a retrospective pa-
tient series from Storli et al., comparing CME with conven-
tional surgery, showed a higher 3-year overall survival (88.1%
vs 79.0%) and disease-free survival (82.1 vs 74.3%) in the
CME group [6]. A Danish retrospective study, published in
2015, reported an improved 4-year disease-free survival
(DFS) in early stage disease with CME surgery, but could
not demonstrate a difference in overall survival [7]. Besides
simple removal of a possible lymphatic metastatic process and
stage migration due to increased lymph node harvest, propo-
nents of the CME technique use a standardization of surgical
technique, resection of possible micrometastases and the pos-
sibility of nodal “skip metastases” as their main arguments
[8–10].
Despite these promising initial results, the quality of evi-
dence supporting the oncological superiority of CME remains
limited. To date, all available patient series have a retrospec-
tive design. Of the 4 studies reporting oncological superior
results with CME surgery [6, 7, 11–13], 2 of them used his-
torical controls [11–13]. One could assume that besides adju-
vant treatment, both peroperative and postoperative care have
evolved, making interpretation of these data difficult. Other
studies have used patient data from other hospitals as their
control group, again complicating interpretation [6, 7, 13].
The remaining studies showed no significant differences in
oncological outcomes after CME, compared to conventional
surgery [13].
As current literature fails to demonstrate an oncological
benefit with the CME technique, concerns are often raised
on intra- and postoperative morbidity. One study reported
higher intraoperative complications during CME surgery
[14]. Most studies show comparable results regarding anasto-
motic leak and postoperative morbidity between both
techniques.
Objectives The purpose of this study is to investigate
short-term outcomes after laparoscopic left-sided
colectomies using the CME technique. By comparing
these data with patients who underwent conventional sur-
gery, we aim to add information on a possible increase in
morbidity when using the CME technique for laparoscop-
ic sigmoid resections.
Materials and methods
Setting This retrospective single center study was conducted
at the surgical department of Maria Middelares Hospital
(Ghent, Belgium). Included patients were treated between
October 2015 and October 2018. Surgery was performed by
three consulting colorectal surgeons. All three of them had
adequate proficiency in colorectal surgery and laparoscopic
CME procedures before the start of the study. Data were ret-
rospectively collected from the electronic patient file and en-
tered in an anonymized database. Before closure of the data-
base on December 1st 2018, data and missing values were
double checked. The study protocol was approved by the local
ethics committee before the start of data collection.
Patients All patients scheduled to undergo elective laparo-
scopic sigmoid resection during the period October 1st
2015–October 1st 2018 were eligible for inclusion.
Exclusion criteria were conversion to laparotomy, combined
procedures, robot-assisted procedures, defunctioning stoma,
obstructive disease, and transanal extraction of the specimen.
Thirteen cases operated by non-participating surgeons (that
are not familiar with the laparoscopic CME technique) and
12 rectal resections (mid-rectal anastomosis or lower) were
excluded. Eventually, 163 patients met the inclusion criteria
and were included for further analysis. Of the included pa-
tients, 66 were operated with a CME technique for malignan-
cy, and 97 patients underwent conventional colectomy for
benign disease. A flowchart of patient numbers is depicted
in Fig. 1.
Surgical technique In the absence of contraindications, me-
chanical bowel preparation was administered. No oral antibi-
otics were given preoperatively. At induction of anesthesia, a
single prophylactic dose of 2 g cefazoline (Cefacidal, Bristol-
Myers Squibb, Braine-l’Alleud, Belgium) and 500 mg of met-
ronidazole (Metronidazol, B. Braun, Diegem, Belgium) was
administered. Surgery for malignancy was performed strictly
adhering to the principles of CME. After a medial-to-lateral
dissection along the mesocolic plane, the inferior mesenteric
vein (IMV) was ligated at the lower border of the pancreas.
The splenic flexure was systematically mobilized, including
Laparoscopic sigmoidal resections
Elective setting 
N=228 
Included in analysis 
n=163 
Exclusion
n=65 
Benign disease
Non-CME resections
n=97 
Malignancy
CME resections
n=66 
- Conversion (n=26) 
- Non-participating surgeons (n=13) 
- (Partial) rectal resection (n=12) 
- Combined procedure (n=8) 
- Robot-assisted (n=5) 
- Defunctioning stoma (n=5) 
- Obstructive disease (n=1) 
- Transanal specimen extraction (n=3) 
Fig. 1 Flowchart for patients included in the analysis
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dissection of the pancreas from the mesocolon and dissection
of the omentum from the transverse colon. A ligation of the
inferior mesenteric artery (IMA) was performed at its origin.
When possible, a double-stapled technique was used, with an
end-to-end circular mechanic anastomosis. Conventional sig-
moid resection for benign disease was performed using a
lateral-to-medial dissection. A mobilization of the splenic
flexure was only performed when necessary to avoid traction,
and the sigmoidal vessels were ligated at 2–3 cm from the
origin of the IMA. Details on bowel preparation and intraop-
erative characteristics are listed in Table 1. An intraoperative
leak test was performed in all cases, except for one anastomo-
sis with a side-to-side (STS) configuration.
Endpoints and variables The rate of anastomotic leak within a
follow-up period of 30 days was defined as the primary end-
point. The reference of Rahbari et al. on the definition and
grading of anastomotic leaks after rectal surgery was used to
define our primary endpoint [15]. Furthermore, overall com-
plications (using the Clavien–Dindo classification), surgical
site infections, intra-abdominal collections, and reoperation
and readmission rates within 30 days were monitored as sec-
ondary endpoints. Data on skin-to-skin operation times, post-
operative hospital stay and specimen length were added to our
database. There were no specific enhanced recovery after sur-
gery (ERAS) measures undertaken during the study period.
Specimen length was measured by the pathology department
between 2 and 5 days after formalin fixation.
Statistical analysis The tested null hypothesis was defined as a
higher short-term complication rate in the group undergoing
CME surgery. For descriptive data on patient demographics
and outcomes, median values and interquartile ranges (IQR)
or proportions (%N) were calculated. Data were checked for
distribution and normality using the Kolmogorov–Smirnov
and Shapiro–Wilk tests. p values were calculated using the
Mann–Whitney U test for continuous variables and Fisher’s
exact test for categorical variables. p values ≤ 0.05 were con-
sidered indicating statistical significance. The Spearman’s
rank correlation coefficient was used to assess a possible cor-
relation between operation times and postoperative hospital
stay. The statistical analysis was performed in a blinded man-
ner and was reviewed by an independent statistician. Data
analysis was carried out using Microsoft Excel (Redmond,
WE, USA), GraphPad (La Jolla, CA, USA), and SPSS
Statistics (North Castle, NY, USA).
Results
Patient characteristics The main characteristics of included
patients are listed in Table 1. Median age in the CME group
was significantly higher than in the non-CME group (68.0
versus 58.7 years, p < 0.001), and significantly more patients
who underwent surgery for malignancy had a high operative
risk. For the other variables, no statistically significant differ-
ence between both groups was shown. TNM stage of 66 pa-
tients in the CME group is shown in Table 2. The majority of
the tumors had a T3–T4 stage (56%); in 63.6% tumors were
nodal negative (N0). Mean andmedian lymph node count was
17.
Endpoints Outcomes are shown in Table 2. Regarding the
primary endpoint, only one grade A leak was observed in
the CME group, for which no surgical or radiological inter-
vention was undertaken. Of the 97 patients who underwent a
conventional colectomy, 3 had an anastomotic leak requiring
surgical intervention. In two cases, this resulted in a left-sided
colostomy; in one case, a local suture repair was done with
placement of a defunctioning ileostomy. One 87-year-old pa-
tient (ASA 3) who underwent conventional colectomy with a
STS anastomosis for recurrent sigmoid volvulus died during
his hospitalization due to anastomotic leak. No major differ-
ences were observed in overall postoperative complications,
surgical site infections, and intra-abdominal collections.
While not statistically significant, there was a trend towards
lower reoperation (1.5% versus 6.2%, p = 0.243) and readmis-
sion rate (4.5% versus 6.2%, p = 0.740) in the CME group
during the first 30 postoperative days. Skin-to-skin operation
times were significantly longer in the CME group (210 versus
184 min, p < 0.001), and a trend towards longer pathological
specimens in the CME group was noted (21 vs 19 cm, p =
0.059). Post hoc power analysis revealed insufficient power to
show significant differences in specimen lengths. Figure 2
depicts a significant correlation between operative times and
postoperative hospital stay (Spearman’s rank correlation coef-
ficient ρ = 0.174, p = 0.027).
Discussion
Main results In a pooled analysis, reported leak rates after both
conventional and CME surgery for colonic cancer were
around 6.0% [13]. In this analysis, data on left-sided, right-
sided, and transverse colectomies were included. Only the
Hohenberger group demonstrated a statistically significant
difference between both groups, with a lower number of anas-
tomotic leaks in their CME group [12]. Again, the historical
controls (dating from the period 1978–1984) remain a major
confounder in these numbers. Recently reported leak rates
after laparoscopic sigmoidectomy for benign disease vary be-
tween 1.2 and 7% [16, 17]. Generally, there is consensus that
preservation of the superior rectal artery (SRA) does not de-
crease leak rates in the surgical treatment of diverticulitis
[16–18]. The outcomes of our study regarding anastomotic
leak are similar. There was a higher proportion of anastomotic
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dehiscence in the surgical treatment of benign disease (3.1%),
and no clinically relevant leaks were observed after CME
surgery.
Generally, all available comparative studies between
CME and conventional colectomy include mainly pa-
tients operated on by open surgery. Only the data from
the Danish Colorectal Cancer Group (DCCG) included
significant numbers of laparoscopic procedures [7, 14].
Concerning operation times, two comparative studies
showed significantly longer procedure times in CME
surgery. However, both of them included only right
hemicolectomies performed by laparotomy [9, 19]. Our
data—indicating a significantly longer operation time for
CME surgery—are in accordance with current literature.
During a consensus meeting in 2014, the three main
elements of CME surgery were defined: first, a sharp
dissection along the embryological plane between the
mesorectal fascia and the retroperitoneum (thereby
resecting an intact mesocolon with all draining lymph
nodes and lymphatics); second, a central vascular tie
Table 1 Patient characteristics and intraoperative variables during laparoscopic left-sided colonic resections
Malignancy (N = 66)
CME resection
Median (IQR) or % (n/N)
Benign disease (N = 97)
Non-CME resection
Median (IQR) or % (n/N)
p valuea
Age (years) 68.0 (60.4–77.1) 58.7 (52.3–68.2) < 0.001*
Gender
Male 54.5% (36/66) 40.2% (39/97)
Female 45.4% (30/66) 59.8% (58/97) 0.080
ASA classification
Low risk (1–2) 75.8% (50/66) 89.7% (87/97) 0.028*
High risk (3–5) 24.2% (16/66) 10.3% (10/97)
Body mass index (kg/m2) 25.7 (23.8–28.7) 26.5 (24.2–29.7) 0.179
Diabetes mellitus
Yes 10.6% (7/66) 7.2% (7/97) 0.057
No 89.4% (59/66) 92.8% (90/97)
Smoking
Current smoker 10.6% (7/66) 22.7% (22/97) 0.059
Non-smoker 89.4% (59/66) 76.3% (74/97)
Missing 0.0% (0/66) 1.0% (1/97)
Bowel preparation
None 4.5% (3/66) 2.1% (2/97)
Mechanical 93.9% (62/66) 89.7% (87/97)
Missing 1.5% (1/66) 8.2% (8/97)
Anastomosis configuration
ETE 100% (66/66) 97.9% (95/97)
ETS 0% (0/66) 1.0% (1/97)
STS 0% (0/66) 1.0% (1/97)
Anastomosis type
Stapled 100% (66/66) 100% (97/97)
Handsewn 0% (0/66) 0% (0/97)
Stapling technique
Circular 100% (66/66) 97.9% (95/97)
Linear 0% (0/66) 2.1% (2/97)
Leak test
Yes 98.5% (65/66) 99.0% (96/97)
No 0% (0/66) 1.0% (1/97)
Missing 1.5% (1/66) 0% (0/97)
CME complete mesocolic excision, IQR interquartile range, ETE end-to-end, ETS end-to-side, STS side-to-side
*Indicating statistical significance
a p values calculated by the Mann–Whitney U test for continuous variables and Fisher’s exact test for categorical variables
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with removal of all central lymph nodes; and third, a
resection of sufficient bowel length to remove pericolic
lymph nodes [8, 20]. The Japanese practice of standard
D3 lymphadenectomy in colon cancer surgery represents
a similar technique to the Western CME concept. In
comparison, both techniques result in pathological spec-
imens with high mesocolic resection plane rates and
equally long distance between the bowel wall and a high
vascular tie. The CME technique however seems to
result in longer specimen lengths and a higher nodal
yield [8, 21, 22]. The pooled data on specimen length
reported by West et al. generally showed longer speci-
men lengths than in our patient series [10, 23]. However,
bowel length was measured after several days of forma-
lin fixation, which reduces specimen length. In the paper
of Storli et al., 10% was added to the specimen length to
correct for previous fixation in formalin [6]. Specific
studies on the topic report reduction in specimen length
Table 2 Outcome variables and tumor characteristics after laparoscopic left-sided colonic resections
Malignancy (N = 66)
CME resection
Median (IQR) or % (n/N)
Benign disease (N = 97)
Non-CME resection
Median (IQR) or % (n/N)
p valuee
Skin-to-skin operation time (minutes) 210.0 (182.8–249.3) 184.0 (163.0–205.0) < 0.001*
Hospital stay (days) 7.0 (6.0–8.8) 7.0 (6.0–8.0) 0.226
Postoperative complicationsa
None 59.1% (39/66) 52.6% (51/97) 0.598
Grades I–IIIa 33.3% (22/66) 41.2% (40/97)
Grades IIIb–IV 7.6% (5/66) 5.2% (5/97)
Grade V 0.0% (0/66) 1.0% (1/97)
Surgical site infection
Yes 1.5% (1/66) 2.1% (2/97) 0.783
No 98.5% (65/66) 97.9% (95/97)
Leakb
None 98.5% (65/66) 96.9% (94/97) 0.108
Grade A 1.5% (1/66) 0.0% (0/97)
Grade B 0.0% (0/66) 0.0% (0/97)
Grade C 0.0% (0/66) 3.1% (3/97)
Intra-abdominal collection
Yes 4.5% (3/66) 2.1% (2/97) 0.395
No 95.5% (63/66) 97.9% (95/97)
Reoperationc
Yes 1.5% (1/66) 6.2% (6/97) 0.243
No 98.5% (65/66) 93.8% (91/97)
Readmissiond
Yes 4.5% (3/66) 6.2% (6/97) 0.740
No 95.5% (63/66) 93.8% (91/97)
Specimen length (cm) 21.0 (18.0–26.0) 19.0 (17.0–24.0) 0.059
T stage
T1 27.3% (18/66)
T2 15.2% (10/66)
T3 51.5% (34/66)
T4 4.5% (3/66)
Missing 1.5% (1/66)
N stage
N0 63.6% (42/66)
N1 13.6% (9/66)
N2 21.2% (14/66)
Missing 1.5% (1/66)
M stage
M0 90.9% (60/66)
M1 7.6% (5/66)
Missing 1.5% (1/66)
CME complete mesocolic excision, IQR interquartile range
*Indicating statistical significance
a According to the Clavien–Dindo classification
bGrade A, no radiological or surgical intervention; grade B, radiological intervention (drain); grade C, surgical intervention
c Reoperation rates during the first 30 postoperative days
d Readmission rates during the first 30 postoperative days
e p values calculated by Mann–Whitney U test for continuous variables and Fisher’s exact test for categorical variables
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of about 30% when comparing unfixed with fixed (yet a
few minutes old) specimens [24]. Most studies on the
topic include left-sided, right-sided, and transverse
colectomies. The only study including only left-sided
colectomies was published by Feng et al. [22]. They
reported significantly longer specimen lengths with the
CME technique than in our results. However, their data
were gathered from fresh specimens, which could partial-
ly explain the differences. On the other hand, median
lymph node count was higher in our study.
Limitations Besides the retrospective design, this study is
subject to several limitations. First, comparing colon can-
cer surgery with the surgical treatment of benign disease
does complicate the interpretation of results. However,
by using conventional colectomies for benign disease as
a control group, this allowed for a control group within
the same time frame, treated by the same surgeons. As
mentioned above, several available patient series use his-
torical controls [11–13] or patients from different surgi-
cal centers as their control group [6, 7, 13]. By using a
control group from our own surgical center, variability in
peroperative and postoperative care was reduced to a
minimum. This implies a rather limited number of pa-
tients included, as only patients of our own center were
included and the inclusion period was limited to 3 years.
Second, one could assume that the conversion thresh-
old is lower in case of malignancy. Indeed, in our num-
bers, most conversion occurred during CME resections
for malignancy. However, our patient cohort does include
a quite large proportion of large tumors (with 56% T3–
T4 tumors) that were not converted. Whether the reason
for conversion was the local (malignant) circumstances
or the technical challenges during CME surgery remains
undetermined. Some surgeons remain hesitant to perform
CME surgery, especially for right-sided colectomies,
where it implicates dissection near the root of the supe-
r i o r me s e n t e r i c v e s s e l s . R ema i n i n g g r o s s l y
underreported, only one study from 2016 (Bertelsen
et al.) reported on higher intraoperative complications
(9.1% CME group vs 3.6% non-CME group, p < 0.001)
during CME surgery [14].
Unlike the length of resected bowel and lymph node
yield, adherence to the mesocolic plane remains
underreported in most patient series. This involves a ded-
icated pathological service, as it requires immediate eval-
uation of the fresh specimen. Mesocolic resection plane
rates are not reported on in our study. As an important
element in CME surgery, it should be included in future
prospective study protocols on the topic.
Conclusion
With this retrospective patient series, we aim to add informa-
tion on outcomes after laparoscopic left-sided CME
colectomies. These results confirm that CME does not in-
crease short-term complications in this patient group.
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